bioRxiv Science⌕ Search

Biology subjects

Morello-Megias, A.

Publications and source records attributed to Morello-Megias, A..

2 recordsLinked to original sources

Molecular anatomy of the entorhinal cortex

The entorhinal cortex (EC) is critical for episodic memory formation and is the epicenter of neurofibrillary tangle formation in Alzheimer's disease. Its cytoarchitectonic and functional heterogeneity has been recognized for decades, but the molecular underpinnings of this heterogeneity are still relatively uncharted. While many features of the region appear to be conserved between rodents and primates, very little is known about the conservation of the molecular identity of EC neurons. Here we perform single-nucleus RNAseq (snRNAseq) of the mouse EC and use in situ hybridization, as well as publicly available transcriptomics data, to enhance the understanding of the heterogeneity of neuron types present in the area. While the well-known dichotomy between lateral and medial EC is evident in superficial layers of EC, we highlight that the medioventral region of EC forms a different population from the caudomedial section. We identify molecular correlates for the previously described parcellation of lateral EC, and show that, at least in layer IIa, subterritories of EC are not separated by abrupt borders but rather form smooth gradients. Lastly, we show that both lateral vs. medial ECIIa markers, and markers that reveal finer grain heterogeneity within ECIIa have conserved patterns of expression in macaque, highlighting the high degree of homology between the two species. Overall this molecular atlas of the mouse EC with some comparative elements is a resource for anatomically-informed molecular studies of the EC and lays the groundwork for mechanistic studies of selective neuronal vulnerability of the region in the context of AD.

neuroscience↗

Cell-type specific profiling of human entorhinal cortex at the onset of Alzheimer's disease neuropathology

Neurons located in layer II of the entorhinal cortex (ECII) are the primary site of pathological tau accumulation and neurodegeneration at preclinical stages of Alzheimers disease (AD). Exploring the alterations that underlie the early degeneration of these cells is essential to develop therapies that curb the disease before symptom onset. Here we performed cell-type specific profiling of human EC at the onset of AD neuropathology. We identify an early response to amyloid pathology by microglia and oligodendrocytes. Importantly, we provide the first insight into neuronal alterations that coincide with incipient tau pathology: the signaling pathway for Reelin, recently shown to be a major AD resilience gene is dysregulated in ECII neurons, while the secreted synaptic organizer molecules NPTX2 and CBLN4, emerging AD biomarkers, are downregulated in surrounding neurons. By uncovering the complex multicellular landscape of EC at these early AD stages, this study paves the way for detailed characterization of the mechanisms governing NFT formation and opens long-needed novel therapeutic avenues.

neuroscience↗